Vera Therapeutics (VERA) Interest Coverage Ratio (2020 - 2026)
Vera Therapeutics (VERA) posted Interest Coverage Ratio of 0.74 for Q1 2026, up 95.74% on a QoQ basis from 17.33 in Q4 2025, and up 84.96% year-over-year from 0.4 in Q1 2025.
Vera Therapeutics (VERA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Vera Therapeutics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.74 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 84.96% year-over-year to 0.74 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.26 (up 53.93% YoY) and the FY2025 annual result came in at 1.21, down 24.96% from the prior year.
- Interest Coverage Ratio was 0.74 for Q1 2026 at Vera Therapeutics, up from 17.33 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.74 in Q1 2026 and bottomed at 66.89 in Q4 2022.
- A 5-year average of 13.52 and a median of 4.91 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio slumped 1252.35% — and 2023, when it jumped 97.11%.
- Vera Therapeutics' Interest Coverage Ratio stood at 66.89 in 2022, then soared by 97.11% to 1.93 in 2023, then plunged by 223.77% to 6.26 in 2024, then plunged by 176.95% to 17.33 in 2025, then surged by 95.74% to 0.74 in 2026.
- Business Quant data shows VERA's Interest Coverage Ratio at 0.74 in Q1 2026, 17.33 in Q4 2025, and 26.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | -0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.74 |
| Dec 31, 2025 | -17.33 |
| Sep 30, 2025 | -26.03 |
| Jun 30, 2025 | -4.29 |
| Mar 31, 2025 | -4.91 |
| Dec 31, 2024 | -6.26 |
| Sep 30, 2024 | -6.26 |
| Jun 30, 2024 | -3.13 |
| Mar 31, 2024 | -4.73 |
| Dec 31, 2023 | -1.93 |
| Sep 30, 2023 | -3.84 |
| Jun 30, 2023 | -17.19 |
| Mar 31, 2023 | -35.76 |
| Dec 31, 2022 | -66.89 |
| Sep 30, 2022 | -2.92 |
| Jun 30, 2022 | -1.74 |
| Mar 31, 2022 | -25.95 |
| Dec 31, 2021 | -829.25 |
| Mar 31, 2021 | -1.92 |
| Dec 31, 2020 | 357.65 |